Researchers from 12 countries gathering at the 5th International Congress on Deuterium Depletion and its satellite Aqua-Synapse research program workshop in Budapest say new findings on the biological role of deuterium could force a fundamental rethink of modern medical therapies. 

 

The Aqua-Synapse workshop was supported by the European Commission’s Research Executive Agency (REA).

 

At the events, scientists from Sweden, the United States, England, China, Russia, Canada, and Hungary presented what organizers described as emerging evidence on the physiological effects of the heavy hydrogen isotope. 

 

The 14 presentations, delivered by researchers from institutions including the Karolinska Institute, Massachusetts Institute of Technology (MIT), Tulane University, and the University of Lisbon, focused on potential clinical implications in cancer and metabolic disease.

 

The conference highlighted research suggesting that deuterium levels may influence key biological processes. “the heavy isotope of hydrogen” was a central focus across multiple talks, with presenters arguing its role may extend beyond passive metabolic tracing.

 

One of the key presentations came from Gábor I. Csonka, professor at Tulane University, who reported findings from experiments on A549 lung cancer cells. 

 

According to his work, “while deuterium enrichment enhances signaling pathways related to inflammation and invasion, deuterium depletion results in their systemic downregulation, directly inhibiting the function of genes responsible for cancer development.” He concluded that “deuterium concentration as a clear modulator of oncogene transcription.”

 

Another prominent voice was Roman A. Zubarev of the Royal Karolinska Institute, who challenged the long-standing “passive isotope” model. He argued that isotopes are not merely inert tracers, stating that “not only hydrogen, but also heavy isotopes of oxygen, nitrogen, and carbon have an active influence on biological systems.” 

 

Zubarev said experimental data suggests “the scientific community is on the verge of a dramatic paradigm shift,” with potential future applications in “deuterium-modulated diets and the control of heavy isotope ratios.”

 

From the University of Lisbon and the Aqua-Synapse program, Tatyana Strekalova presented animal research on deuterium-depleted water (DDW), reporting “protective effects” alongside behavioral and neurological changes. 

 

She observed “increased hedonic sensitivity (increased susceptibility to positive stimuli and pleasure), novelty discovery, and improved memory,” as well as altered expression of genes linked to stress response, neural plasticity, and regeneration.

 

HYD LLC. chief researcher Gábor Somlyai outlined broader claims about the role of the deuterium-to-hydrogen ratio in tumor metabolism and metabolic disorders such as diabetes. 

 

He argued that “the optimal deuterium concentration for proper insulin signaling lies between 125 and 140 ppm,” and suggested that current dietary patterns may contribute to elevated deuterium levels in the general population. Somlyai also referenced clinical evidence, stating that “integrating deuterium depletion into conventional cancer treatment protocols could reduce cancer mortality by 75–80%.”

 

Alongside the scientific presentations, industry participants at the conference emphasized the potential commercial and translational applications of deuterium-based technologies, pointing to growing international interest in the field and its development based on Hungarian research leadership.